|
1
|
Testa U, Pelosi E and Castelli G:
Colorectal cancer: Genetic abnormalities, tumor progression, tumor
heterogeneity, clonal evolution and tumor-initiating cells. Med Sci
(Basel). 6:E312018.PubMed/NCBI
|
|
2
|
Merlano MC, Granetto C, Fea E, Ricci V and
Garrone O: Heterogeneity of colon cancer: From bench to bedside.
ESMO Open. 2:e0002182017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Eljaszewicz A, Gackowska L, Kubiszewska I,
Jankowski M, Urbańska M, Wiese M, Helmin-Basa A, Michałkiewicz J
and Zegarski W: Aktywność makrofagów w rozwoju choroby
nowotworowej. Współczesna Onkologia. 1:1–6. 2010.(In Poland).
View Article : Google Scholar
|
|
4
|
Hong-Fang T, Yan-Hui P, Lei B and Wan-Xing
Z: Effects of granulocyte colony-stimulating factor on opsonin
receptor expression and neutrophil antibacterial activity in a
mouse model of severe acute pancreatitis. Postepy Hig Med Dosw
(Online). 71:352–358. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dubois RN: Role of inflammation and
inflammatory mediators in colorectal cancer. Trans Am Clin Climatol
Assoc. 125:358–372; discussion 372–373. 2014.PubMed/NCBI
|
|
6
|
Dunn GP, Old LJ and Schreiber RD: The
immunobiology of cancer immunosurveillance and immunoediting.
Immunity. 21:137–148. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
McCourt M, Wang JH, Sookhai S and Redmond
HP: Activated human neutrophils release hepatocyte growth
factor/scatter factor. Eur J Surg Oncol. 27:396–403. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shamamian P, Schwartz JD, Pocock BJ, Monea
S, Whiting D, Marcus SG and Mignatti P: Activation of progelatinase
A (MMP-2) by neutrophil elastase, cathepsin G, and proteinase-3: A
role for inflammatory cells in tumor invasion and angiogenesis. J
Cell Physiol. 189:197–206. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Prizment AE, Vierkant RA, Smyrk TC,
Tillmans LS, Lee JJ, Sriramarao P, Nelson HH, Lynch CF, Thibodeau
SN, Church TR, et al: Tumor eosinophil infiltration and improved
survival of colorectal cancer patients: Iowa women's health study.
Mod Pathol. 29:516–527. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
NCCN Clinical Practice Guidelines in
Oncology, . Colon Cancer. https://www.nccn.org.asp
|
|
11
|
Kyriakos M: The President cancer, the
Dukes classification, and confusion. Arch Pathol Lab Med.
109:1063–1066. 1985.PubMed/NCBI
|
|
12
|
Therasse P, Arbuck SG, Eisenhauer EA,
Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van
Oosterom AT, Christian MC and Gwyther SG: New guidelines to
evaluate the response to treatment in solid tumors. European
organization for research and treatment of cancer, national cancer
institute of the United States, national cancer institute of
Canada. J Natl Cancer Inst. 92:205–216. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lin Q, Wei Y, Ren L, Zhong Y, Qin C, Zheng
P, Xu P, Zhu D, Ji M and Xu J: Tumor deposit is a poor prognostic
indicator in patients who underwent simultaneous resection for
synchronous colorectal liver metastases. Onco Targets Ther.
8:233–240. 2015.PubMed/NCBI
|
|
14
|
Huijbers A, Tollenaar RA, v Pelt GW,
Zeestraten EC, Dutton S, McConkey CC, Domingo E, Smit VT, Midgley
R, Warren BF, et al: The proportion of tumor-stroma as a strong
prognosticator for stage II and III colon cancer patients:
Validation in the VICTOR trial. Ann Oncol. 24:179–185. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Morodomi T, Isomoto H, Shirouzu K,
Kakegawa K, Irie K and Morimatsu M: An index for estimating the
probability of lymph node metastasis in rectal cancers. Lymph node
metastasis and the histopathology of actively invasive regions of
cancer. Cancer. 63:539–543. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Klintrup K, Mäkinen JM, Kauppila S, Väre
PO, Melkko J, Tuominen H, Tuppurainen K, Mäkelä J, Karttunen TJ and
Mäkinen MJ: Inflammation and prognosis in colorectal cancer. Eur J
Cancer. 41:2645–2654. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Richards CH, Flegg KM, Roxburgh CS, Going
JJ, Mohammed Z, Horgan PG and McMillan DC: The relationships
between cellular components of the peritumoural inflammatory
response, clinicopathological characteristics and survival in
patients with primary operable colorectal cancer. Br J Cancer.
106:2010–2015. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Väyrynen JP, Sajanti SA, Klintrup K,
Mäkelä J, Herzig KH, Karttunen TJ, Tuomisto A and Mäkinen MJ:
Characteristics and significance of colorectal cancer associated
lymphoid reaction. Int J Cancer. 134:2126–2135. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ueno H, Jones AM, Wilkinson KH, Jass JR
and Talbot IC: Histological categorization of fibrotic cancer
stroma in advanced rectal cancer. Gut. 53:581–586. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lichtman MA, Kipps TJ, Seligsohn U,
Kaushansky K and Prchal JT: Williams Hematology. (8th). McGraw-Hill
Companies. 875–999. 2010.
|
|
21
|
Nowak B: Patomechanizm rozwoju reakcji
zapalnej. Przegl Reumatol. R.1 nr 4; s.5. 2005.
|
|
22
|
Rao HL, Chen JW, Li M, Xiao YB, Fu J, Zeng
YX, Cai MY and Xie D: Increased intratumoral neutrophil in
colorectal carcinomas correlates closely with malignant phenotype
and predicts patients' adverse prognosis. PLoS One. 7:e308062012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Arelaki S, Arampatzioglou A, Kambas K,
Papagoras C, Miltiades P, Angelidou I, Mitsios A, Kotsianidis I,
Skendros P, Sivridis E, et al: Gradient infiltration of neutrophil
extracellular traps in colon cancer and evidence for their
involvement in tumour growth. PLoS One. 11:e01544842016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Galdiero MR, Bianchi P, Grizzi F, Di Caro
G, Basso G, Ponzetta A, Bonavita E, Barbagallo M, Tartari S,
Polentarutti N, et al: Occurrence and significance of
tumor-associated neutrophils in patients with colorectal cancer.
Int J Cancer. 139:446–456. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mizuno R, Kawada K, Itatani Y, Ogawa R,
Kiyasu Y and Sakai Y: The role of tumor-associated neutrophils in
colorectal cancer. Int J Mol Sci. 20:E5292019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mlecnik B, Tosolini M, Kirilovsky A,
Berger A, Bindea G, Meatchi T, Bruneval P, Trajanoski Z, Fridman
WH, Pagès F and Galon J: Histopathologic-based prognostic factors
of colorectal cancers are associated with the state of the local
immune reaction. J Clin Oncol. 29:610–618. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kiziltaş S, Sezgin Ramadan S, Topuzoğlu A
and Küllü S: Does the severity of tissue eosinophilia of colonic
neoplasms reflect their malignancy potential? Turk J Gastroenterol.
19:239–244. 2008.PubMed/NCBI
|
|
28
|
Cho H, Lim SJ, Won KY, Bae GE, Kim GY, Min
JW and Noh BJ: Eosinophils in colorectal neoplasms associated with
expression of CCL11 and CCL24. J Pathol Transl Med. 50:45–51. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Moezzi J, Gopalswamy N, Haas RJ Jr,
Markert RJ, Suryaprasad S and Bhutani MS: Stromal eosinophilia in
colonic epithelial neoplasms. Am J Gastroenterol. 95:520–523. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Harbaum L, Pollheimer MJ, Kornprat P,
Lindtner RA, Bokemeyer C and Langner C: Peritumoral eosinophils
predict recurrence in colorectal cancer. Mod Pathol. 28:403–413.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mantovani A, Bottazzi B, Colotta F,
Sozzani S and Ruco L: The origin and function of tumor-associated
macrophages. Immunol Today. 13:265–270. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Leek RD, Lewis CE, Whitehouse R, Greenall
M, Clarke J and Harris AL: Association of macrophage infiltration
with angiogenesis and prognosis in invasive breast carcinoma.
Cancer Res. 56:4625–4629. 1996.PubMed/NCBI
|
|
33
|
Mantovani A: Tumor-associated macrophages
in neoplastic progression: A paradigm for the in vivo function of
chemokines. Lab Invest. 71:5–16. 1994.PubMed/NCBI
|
|
34
|
Afik R, Zigmond E, Vugman M, Klepfish M,
Shimshoni E, Pasmanik-Chor M, Shenoy A, Bassat E, Halpern Z, Geiger
T, et al: Tumor macrophages are pivotal constructors of tumor
collagenous matrix. J Exp Med. 213:2315–2331. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ohtani H, Naito Y, Saito K and Nagura H:
Expression of costimulatory molecules B7-1 and B7-2 by macrophages
along invasive margin of colon cancer: A possible antitumor
immunity? Lab Invest. 77:231–241. 1997.PubMed/NCBI
|
|
36
|
Khorana AA, Ryan CK, Cox C, Eberly S and
Sahasrabudhe DM: Vascular endothelial growth factor, CD68, and
epidermal growth factor receptor expression and survival in
patients with Stage II and Stage III colon carcinoma: A role for
the host response in prognosis. Cancer. 97:960–968. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hamilton SR, Bosman FT, Boffetta P, et al:
Carcinoma of the colon and rectum In: WHO classification of tumours
of the digestive system. Bosman FT, Carneiro F, Hruban RH and
Theise ND: (4th). IARC. (Lyon). 134–146. 2010.
|
|
38
|
Popovic ZV, Sandhoff R, Sijmonsma TP,
Kaden S, Jennemann R, Kiss E, Tone E, Autschbach F, Platt N, Malle
E and Gröne HJ: Sulfated glycosphingolipid as mediator of
phagocytosis: SM4s enhances apoptotic cell clearance and modulates
macrophage activity. J Immunol. 179:6770–6782. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Funada Y, Noguchi T, Kikuchi R, Takeno S,
Uchida Y and Gabbert HE: Prognostic significance of CD8+ T cell and
macrophage peritumoral infiltration in colorectal cancer. Oncol
Rep. 10:309–313. 2003.PubMed/NCBI
|
|
40
|
Zhou Q, Peng RQ, Wu XJ, Xia Q, Hou JH,
Ding Y, Zhou QM, Zhang X, Pang ZZ, Wan DS, et al: The density of
macrophages in the invasive front is inversely correlated to liver
metastasis in colon cancer. J Transl Med. 8:132010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Koelzer VH, Canonica K, Dawson H, Sokol L,
Karamitopoulou-Diamantis E, Lugli A and Zlobec I: Phenotyping of
tumor-associated macrophages in colorectal cancer: Impact on single
cell invasion (tumor budding) and clinicopathological outcome.
Oncoimmunology. 5:e11066772015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ammendola M, Patruno R, Sacco R, Marech I,
Sammarco G, Zuccalà V, Luposella M, Zizzo N, Gadaleta C, Porcelli
M, et al: Mast cells positive to tryptase and tumour-associated
macrophages correlate with angiogenesis in locally advanced
colorectal cancer patients undergone to surgery. Expert Opin Ther
Targets. 20:533–540. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Gulubova M, Ananiev J, Yovchev Y, Julianov
A, Karashmalakov A and Vlaykova T: The density of macrophages in
colorectal cancer is inversely correlated to TGF-β1 expression and
patients' survival. J Mol Histol. 44:679–692. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kinouchi M, Miura K, Mizoi T, Ishida K,
Fujibuchi W, Sasaki H, Ohnuma S, Saito K, Katayose Y, Naitoh T, et
al: Infiltration of CD40-positive tumor-associated macrophages
indicates a favorable prognosis in colorectal cancer patients.
Hepatogastroenterology. 60:83–88. 2013.PubMed/NCBI
|
|
45
|
Fernández-Aceñero MJ, Galindo-Gallego M,
Sanz J and Aljama A: Prognostic influence of tumor-associated
eosinophilic infiltrate in colorectal carcinoma. Cancer.
88:1544–1548. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wikberg ML, Ling A, Li X, Öberg Å, Edin S
and Palmqvist R: Neutrophil infiltration is a favorable prognostic
factor in early stages of colon cancer. Hum Pathol. 68:193–202.
2017. View Article : Google Scholar : PubMed/NCBI
|
